First gene therapy to go on sale in 2013

c gene therapy conc

The first gene therapy to be approved in a regulated market was announced by the European Commission, which granted its approval to a treatment for the rare inherited disorder lipoprotein lipase deficiency (LPL). This genetic disorder leaves people unable to store fat in adipose and muscle cells. The new drug has been named Glybera by its maker, UniQure. The therapy, which manufacturers say will be available next year, uses a virus to insert a working copy of the gene into muscle.

Related Articles:

 

View the original article here: http://www.bbc.co.uk/news/health-20179561

Outbreak
Outbreak Daily Digest
Biotech Facts & Fallacies
Talking Biotech
Genetics Unzipped
Infographic: What are mRNA COVID-19 vaccines and how do they work?

Infographic: What are mRNA COVID-19 vaccines and how do they work?

As of 1 December 2020, thirteen vaccines have reached the final stage of testing: where they are being given to ...
favicon

Environmental Working Group: EWG challenges safety of GMOs, food pesticide residues

Known by some as the "Environmental Worrying Group," EWG lobbies ...
m hansen

Michael Hansen: Architect of Consumers Union ongoing anti-GMO campaign

Michael K. Hansen (born 1956) is thought by critics to be ...
News on human & agricultural genetics and biotechnology delivered to your inbox.
glp menu logo outlined

Newsletter Subscription

Optional. Mail on special occasions.
Send this to a friend